KPV is only three amino acids long. Yet published research shows it carries much of the anti-inflammatory power of a far larger hormone. It does this without the pigmentation effects of its parent molecule, and without broadly suppressing the immune system. This overview covers what the literature shows about how such a small peptide does so much.
KPV is a tripeptide. It corresponds to the final three amino acids of alpha-MSH — alpha-melanocyte-stimulating hormone — a natural anti-inflammatory hormone produced in the body. Researchers discovered that most of alpha-MSH’s anti-inflammatory activity could be preserved in this much smaller fragment.
Critically, KPV lacks the pigmentation and appetite effects of the full hormone. That separation is what makes it useful as a focused research tool.
Catania A. The melanocortin system in leukocyte biology. J Leukoc Biol. 2007.
The central mechanism of KPV involves NF-kB. NF-kB is a master switch for inflammatory gene expression — when it activates, cells produce inflammatory signals. When it is calmed, they stop.
Published research shows KPV enters cells directly and inhibits NF-kB activation. Notably, it does this without needing to activate a cell-surface receptor. As a result, it reduces production of multiple inflammatory signals — including TNF-alpha, IL-1beta, and IL-6 — at the same time.
Dalmasso G, et al. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. 2008.
The strongest single dataset on KPV comes from gut research. A 2008 Gastroenterology study showed that oral KPV reduced intestinal inflammation in two mouse colitis models. It worked through a transporter called PepT1 and the NF-kB pathway.
One detail makes this especially interesting. PepT1 is upregulated in inflamed intestinal tissue. In other words, inflamed cells absorb more KPV, delivering the compound precisely where inflammation is highest. The research describes it as self-targeting.
KPV research extends beyond the gut. In skin models, published studies report that KPV suppresses contact hypersensitivity and reduces inflammatory cytokine production in keratinocytes. A 2025 study examined KPV against particulate-matter-induced skin inflammation and reported inhibition of the MAPK and NF-kB inflammatory axis.
Alpha-MSH-derived peptides, including KPV, have also shown antimicrobial activity against certain bacteria and fungi in published research.
KPV inhibits the ERK/p38 MAPK/NF-kB axis in particulate-matter-induced skin inflammation. 2025.
| What the Research Doesn’t Say No registered human clinical trials exist for KPV as a single-ingredient compound. All evidence comes from cell and animal studies. The strongest data is preclinical but roughly two decades deep, centered on gut and skin inflammation models. Animal model results do not guarantee equivalent effects or safety in humans. |
What is KPV?
KPV is a tripeptide made of three amino acids — lysine, proline, and valine. It is the final fragment of the natural anti-inflammatory hormone alpha-MSH, retaining anti-inflammatory activity without pigmentation effects.
How does KPV reduce inflammation?
KPV enters cells and directly inhibits NF-kB, a master regulator of inflammatory gene expression. This reduces multiple inflammatory signals at once, without requiring a cell-surface receptor and without broadly suppressing the immune system.
Why is KPV studied for gut health?
A 2008 Gastroenterology study showed oral KPV reduced intestinal inflammation in mouse colitis models. It is absorbed through the PepT1 transporter, which is more active in inflamed tissue — effectively self-targeting to areas of highest inflammation.
How does KPV relate to the KLOW blend?
KPV is one component of the KLOW research blend, alongside GHK-Cu, BPC-157, and TB-500. In that blend, KPV contributes the NF-kB anti-inflammatory dimension. It is also available as a standalone research compound.
For informational purposes only. This article is a research literature review. KPV is available from Brava Longevity for research use only. Not intended for human or veterinary consumption. Not medical advice.
